Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT

被引：9
作者：
Sarafidis, Pantelis [1 ]
Loutradis, Charalampos [1 ]
Ortiz, Alberto [2 ,3 ]
Ruilope, Luis M. [4 ,5 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Nephrol, Hippokrat Hosp, Thessaloniki, Greece
[2] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, FRIAT, Sch Med, Madrid, Spain
[3] REDINREN, Madrid, Spain
[4] Hosp Univ 12 Octubre, Inst Res I 12, Madrid, Spain
[5] Univ Europea Madrid, Sch Doctoral Studies & Res, Madrid, Spain
来源：
CLINICAL KIDNEY JOURNAL | 2020年 / 13卷 / 03期
关键词：
blood pressure targets; chronic kidney disease; end-stage kidney disease; hypertension; mortality; renal outcomes; PROGRESSION; HYPERTENSION; REDUCTION; DIET;
D O I：
10.1093/ckj/sfaa015
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recent American and European hypertension guidelines are not in agreement regarding blood pressure (BP) targets for persons with chronic kidney disease (CKD). Previous analyses from the African American Study on Kidney Disease (AASK) and Modification of Diet in Renal Disease (MDRD) trials suggested that strict BP control confers nephroprotection for patients with proteinuria, but a mortality benefit was not apparent. In contrast, an analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) subpopulation of CKD patients showed a mortality benefit with the systolic blood pressure (SBP)<120mmHg versus the SBP<140 target. A recent analysis of the combined MDRD and AASK cohorts supports previous evidence on nephroprotection but also findings from the SPRINT trial on all-cause mortality benefits of intensive versus usual BP control in individuals with CKD.
引用
收藏
页码：287 / 290
页数：4
相关论文
共 16 条
  • [1] Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
    Appel, Lawrence J.
    Wright, Jackson T., Jr.
    Greene, Tom
    Agodoa, Lawrence Y.
    Astor, Brad C.
    Bakris, George L.
    Cleveland, William H.
    Charleston, Jeanne
    Contreras, Gabriel
    Faulkner, Marquetta L.
    Gabbai, Francis B.
    Gassman, Jennifer J.
    Hebert, Lee A.
    Jamerson, Kenneth A.
    Kopple, Joel D.
    Kusek, John W.
    Lash, James P.
    Lea, Janice P.
    Lewis, Julia B.
    Lipkowitz, Michael S.
    Massry, Shaul G.
    Miller, Edgar R.
    Norris, Keith
    Phillips, Robert A.
    Pogue, Velvie A.
    Randall, Otelio S.
    Rostand, Stephen G.
    Smogorzewski, Miroslaw J.
    Toto, Robert D.
    Wang, Xuelei
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) : 918 - 929
  • [2] The chaos of hypertension guidelines for chronic kidney disease patients COMMENT
    Castillo-Rodriguez, Esmeralda
    Fernandez-Fernandez, Beatriz
    Alegre-Bellassai, Raquel
    Kanbay, Mehmet
    Ortiz, Alberto
    [J]. CLINICAL KIDNEY JOURNAL, 2019, 12 (06) : 771 - 777
  • [3] THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE
    KLAHR, S
    LEVEY, AS
    BECK, GJ
    CAGGIULA, AW
    HUNSICKER, L
    KUSEK, JW
    STRIKER, G
    BUCKALEW, V
    BURKART, J
    FURBERG, C
    FELTS, J
    MOORE, M
    ROCCO, H
    DOLECEK, T
    WARREN, S
    BEARDEN, B
    STARKEY, C
    HARVEY, J
    POOLE, D
    DAHLQUIST, S
    DOROSHENKO, L
    BRADHAM, K
    WEST, D
    AGOSTINO, J
    COLE, L
    BAKER, B
    HAIRSTON, K
    BURGOYNE, S
    LAZARUS, J
    STEINMAN, T
    SEIFTER, J
    DESMOND, M
    FIORENZO, M
    CHIAVACCI, A
    METALIDES, T
    KORZECRAMIREZ, D
    GOULD, S
    PICKETT, V
    PORUSH, J
    FAUBERT, P
    SPITALEWITZ, S
    FAUBERT, J
    ZIMMER, G
    SAUM, D
    BLOCK, M
    WOEL, J
    ROSE, M
    DENNIS, V
    SCHWAB, S
    MINDA, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) : 877 - 884
  • [4] Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease
    Ku, Elaine
    Sarnak, Mark J.
    Toto, Robert
    McCulloch, Charles E.
    Lin, Feng
    Smogorzewski, Miroslaw
    Hsu, Chi-yuan
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (16):
  • [5] Vascular Access for Hemodialysis and Value-Based Purchasing for ESRD
    Mehrotra, Rajnish
    Cheung, Alfred K.
    Meyer, Timothy
    Nath, Karl A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (02): : 395 - 397
  • [6] BLOOD-PRESSURE CONTROL, PROTEINURIA, AND THE PROGRESSION OF RENAL-DISEASE - THE MODIFICATION OF DIET IN RENAL-DISEASE STUDY
    PETERSON, JC
    ADLER, S
    BURKART, JM
    GREENE, T
    HEBERT, LA
    HUNSICKER, LG
    KING, AJ
    KLAHR, S
    MASSRY, SG
    SEIFTER, JL
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (10) : 754 - +
  • [7] Hypertension awareness, treatment, and control in chronic kidney disease
    Sarafidis, Pantelis A.
    Li, Suying
    Chen, Shu-Cheng
    Collins, Allan J.
    Brown, Wendy W.
    Klag, Michael J.
    Bakris, George L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (04) : 332 - 340
  • [8] Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME
    Sarafidis, Pantelis A.
    Lazaridis, Antonios A.
    Ruiz-Hurtado, Gema
    Ruilope, Luis M.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (06) : 365 - 374
  • [9] Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis, Pantelis A.
    Ruilope, Luis M.
    [J]. KIDNEY INTERNATIONAL, 2014, 85 (03) : 536 - 546
  • [10] Sarafidis PA, 2013, BLOOD PRESSURE, V22, P395
12